Preparation of 177Lu-labeled Nimotuzumab for radioimmunotherapy of EGFR-positive cancers: Comparison of DOTA and CHX-A″-DTPA as bifunctional chelators

dc.contributor.authorPandey, U.
dc.contributor.authorKameswaran, M.
dc.contributor.authorGamre, N.
dc.contributor.authorDash, A.
dc.date.accessioned2020-11-09T06:26:53Z
dc.date.available2020-11-09T06:26:53Z
dc.date.issued2019
dc.description.divisionRPhDen
dc.format.extent4883 bytes
dc.format.mimetypetext/html
dc.identifier.sourceJournal of Labelled Compounds and Radiopharmaceuticals, 2019. Vol. 62: pp. 158-165en
dc.identifier.urihttp://hdl.handle.net/123456789/21220
dc.language.isoenen
dc.subjectEGFRen
dc.subjectNimotuzumaben
dc.subjectradioimmunotherapyen
dc.subject177Lu‐CHX‐A″‐DTPA‐Nimotuzumaben
dc.subject177 Lu‐DOTA‐Nimotuzumaben
dc.titlePreparation of 177Lu-labeled Nimotuzumab for radioimmunotherapy of EGFR-positive cancers: Comparison of DOTA and CHX-A″-DTPA as bifunctional chelatorsen
dc.typeArticleen

Click here to download

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
0938.htm
Size:
4.77 KB
Format:
Hypertext Markup Language
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.81 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections